| scholarly article | Q13442814 |
| P2093 | author name string | Jung-Joon Min | |
| Daejin Lim | |||
| Hyon E Choy | |||
| Jae-Ho Jeong | |||
| Hyun-Ju Kim | |||
| Joon Haeng Rhee | |||
| Geun-Joong Kim | |||
| Kwangsoo Kim | |||
| Minsang Shin | |||
| Ho-Dong Lim | |||
| Sung-Hwan You | |||
| Kyeongil Park | |||
| Sa-Young Min | |||
| P2860 | cites work | Identification of genes and gene products necessary for bacterial bioluminescence | Q24595152 |
| Diffusion of autoinducer is involved in regulation of the Vibrio fischeri luminescence system | Q24678216 | ||
| Salmonella and cancer: from pathogens to therapeutics | Q27015676 | ||
| Use of ?-asparaginase in childhood ALL | Q29041017 | ||
| Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium | Q30491729 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| Bacterial bioluminescence: isolation and genetic analysis of functions from Vibrio fischeri | Q34271153 | ||
| Structural identification of autoinducer of Photobacterium fischeri luciferase | Q34282298 | ||
| A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy | Q34315760 | ||
| Asparagine synthetase: regulation by cell stress and involvement in tumor biology | Q34327474 | ||
| A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
| Engineering and visualization of bacteria for targeting infarcted myocardium | Q34994526 | ||
| Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins. | Q35001857 | ||
| Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3). | Q35004007 | ||
| Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. | Q35067893 | ||
| Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma. | Q53144955 | ||
| Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase | Q73879722 | ||
| Quorum-sensing Salmonella selectively trigger protein expression within tumors | Q35212564 | ||
| Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice. | Q35735164 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Synergistic binding of the Vibrio fischeri LuxR transcriptional activator domain and RNA polymerase to the lux promoter region. | Q35994991 | ||
| Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model | Q36097450 | ||
| Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy | Q36189385 | ||
| Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | Q36191597 | ||
| L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors | Q36838520 | ||
| Salmonella enterica serovar gallinarum requires ppGpp for internalization and survival in animal cells | Q36933192 | ||
| Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model. | Q37022286 | ||
| Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging | Q37118741 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. | Q37311260 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model. | Q37362834 | ||
| Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
| A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety | Q37562460 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model | Q37699156 | ||
| Salmonella-allies in the fight against cancer | Q37762990 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. | Q39837601 | ||
| L-Asparaginase: A Review | Q39931950 | ||
| Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
| A bacterial protein enhances the release and efficacy of liposomal cancer drugs | Q40204842 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy | Q40937873 | ||
| ppGpp-mediated stationary phase induction of the genes encoded by horizontally acquired pathogenicity islands and cob/pdu locus in Salmonella enterica serovar Typhimurium | Q43134134 | ||
| Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma | Q43161957 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model | Q44538901 | ||
| Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients | Q44591603 | ||
| Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
| Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide. | Q46020823 | ||
| Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model | Q46326758 | ||
| Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). | Q46675243 | ||
| Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin | Q47587450 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium | Q50043645 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8548-8559 | |
| P577 | publication date | 2018-01-05 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella | |
| P478 | volume | 9 |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
Search more.